Developing vaccines against potential pandemic influenza viruses

International Congress Series

Volumn 1219, Issue C, 2001, Pages 751-759

  Wood, J M ^a   Nicholson, K G ^b   Zambon, M ^c   Hinton, R ^d   Major, D L ^a   Newman, R W ^a   Dunleavy, U ^a   Melzack, D ^a   Robertson, J S ^a   Schild, G C ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

H5N1 vaccines; H9N2 vaccines

Indexed keywords

EID: 85009019233     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00385-5     Document Type: Article

References (19)

1. Bender, C., Hall, H., Huang, J., Klimov, A., Cox, N., Hay, A., Gregory, V., Cameron, K., Lim, W., Subbarao, K., Characterisation of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997–1998. Virology 254 (1999), 115–123.
2. Peiris, M., Yuen, K.Y., Leung, C.W., Chan, K.H., Ip, P.L.S., Lai, R.W.M., Orr, W.K., Shortridge, K.F., Human infection with influenza H9N2. Lancet 354 (1999), 916–917.
3. Guo, Y., Li, J.W., Cheng, I., Discovery of humans infected by avian influenza A (H9N2) virus. Chin. J. Exp. Clin. Virol. 15 (1999), 105–108.
4. Shortride, K.F., Zhou, N.N., Guan, Y., Gao, P., Ito, T., Kawaoka, Y., Kodihalli, S., Krauss, S., Markwell, D., Murti, K.G., Norwood, M., Senne, D., Sims, L., Takada, A., Webster, R.G., Characterisation of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252 (1998), 331–342.
5. Guo, Y.J., Krauss, S., Senne, D.A., Mo, I.P., Lo, K.S., Xiong, X.P., Norwood, M., Shortridge, K.F., Webster, R.G., Guan, Y., Characterisation of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology 267 (2000), 279–288.
6. Influenza Pandemic Preparedness Plan, 1999, WHO, Geneva, Switzerland.
7. Li, S., Liu, C., Klimov, A., Subbarao, K., Perdue, M., Mo, D., Ji, Y., Woods, L., Hietala, S., Bryant, M., Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179 (1999), 1132–1138.
8. Takada, A., Kuboki, N., Okazaki, K., Ninomiya, A., Tanaka, H., Ozaki, H., Itamura, S., Nishimura, H., Enami, M., Tashiro, M., Shortridge, K.F., Kida, H., Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J. Virol. 73 (1999), 8303–8307.
9. Mabrouk, Vaccines and related biological products advisory committee meeting regarding influenza vaccine formulation for 1999–2000. 1999. www.fda.gov/ohrms/dockets/ac/99/transcpt/3494t1.
10. J.M. Wood, Vaccines and related biological products advisory committee meeting regarding influenza vaccine formulation for 1999–2000. 1999. www.fda.gov/ohrms/dockets/ac/99/transcpt/3494t1.
11. Crawford, J., Wilkinson, B., Vosnesensky, A., Smith, G., Garcia, M., Stone, H., Perdue, M.L., Baculovirus-derived haemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17 (1999), 2265–2274.
12. Katz, J. Treanor, Vaccines and related biological products advisory committee meeting regarding influenza vaccine formulation for 1999–2000. 1999. www.fda.gov/ohrms/dockets/ac/99/transcpt/3494tl.
13. Treanor, J.J., Wilkinson, B., Blackwelder, W., Katz, J.M., Evaluation of the haemagglutinin (HA) of the H5N1 influenza A/Hong Kong/156/97 virus expressed in insect cells by recombinant baculovirus (rH5) as an influenza vaccine in healthy adults. [Abstract No. 682], 39th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999.
14. Wood, J.M., Major, D., Daly, J., Newman, R.W., Dunleavy, U., Nicholson, C., Robertson, J.S., Schild, G.C., Vaccines against H5N1 influenza. Lett. Vaccine 19 (2000), 579–580.
15. Lu, X., Tumpey, T.M., Morken, T., Zaki, S.R., Cox, N.J., Katz, J.M., A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73 (1999), 5903–5911.
16. Major, D., Newman, R.W., Dunleavy, U., Heath, A., Ploss, K., Wood, J.M., Evaluation of candidate H9N2 influenza vaccine strains in BalbC mice. Osterhaus, A.D.M.E., et al. (eds.) Options for the Control of Influenza IV Exerpta Med. Int. Congr. Ser., 2001, Elsevier, 789–794.
17. Kodihalli, S., Goto, H., Kobasa, D.L., Krauss, S., Kawaoka, Y., Webster, R.G., DNA vaccine encoding haemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73 (1999), 2094–2098.
18. Rimmelzwaan, G.F., Claas, E.C.J., Van Amerongen, G., de Jong, J.C., Osterhaus, A.D.M.E., ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus. Vaccine 17 (1999), 1355–1358.
19. Rowe, T., Abernathy, R.A., Hu-Primmer, J., Thompson, W.W., Lu, X., Lin, W., Fukuda, K., Cox, N.J., Katz, J.M., Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serological assays. J. Clin. Microbiol. 37 (1999), 937–943.